Antivirals Reduce the Formation of Key Alzheimer's Disease Molecules in Cell Cultures Acutely Infected with Herpes Simplex Virus Type 1
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) afflicts around 20 million people worldwide and so there is an urgent need for effective treatment. Our research showing that herpes simplex virus type 1 (HSV1) is a risk factor for AD for the brains of people who possess a specific genetic factor and that the virus causes accumulation of key AD proteins (β-amyloid (Aβ) and abnormally phosphorylated tau (P-tau)), suggests that anti-HSV1 antiviral agents might slow AD progression. However, currently available antiviral agents target HSV1 DNA replication and so might be successful in AD only if Aβ and P-tau accumulation depend on viral DNA replication. Therefore, we investigated firstly the stage(s) of the virus replication cycle required for Aβ and P-tau accumulation, and secondly whether antiviral agents prevent these changes using recombinant strains of HSV1 that progress only partly through the replication cycle and antiviral agents that inhibit HSV1 DNA replication. By quantitative immunocytochemistry we demonstrated that entry, fusion and uncoating of HSV1, are insufficient to induce Aβ and P-tau production. We showed also that none of the "immediate early" viral proteins is directly responsible, and that Aβ and P-tau are produced at a subsequent stage of the HSV1 replication cycle. Importantly, the anti-HSV1 antiviral agents acyclovir, penciclovir and foscarnet reduced Aβ and P-tau accumulation, as well as HSV1, with foscarnet being less effective in each case. P-tau accumulation was found to depend on HSV1 DNA replication, whereas Aβ accumulation was not. The antiviral-induced decrease in Aβ is attributable to the reduced number of new viruses, and hence the reduction in viral spread. Since antiviral agents reduce greatly Aβ and P-tau accumulation in HSV1-infected cells, they would be suitable for treating AD with great advantage unlike current AD therapies, only the virus, not the host cell, would be targeted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Honess, R. W., & Roizman, B. (1974) · Journal of Virology · doi:10.1128/jvi.14.1.8-19.1974 · Cited by 1,414 · cited 2×
“We found that staining for gC (a late protein that is dependent on DNA replication) was reduced to less than 1% of the value in the absence of antiviral, whereas staining for ICP0 (an IE protein) and UL42 (an early protein), which are independent of viral DNA replication [17], was reduced but not to the same extent (t…”
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease
Itzhaki, R. F., Lin, W.-R., Shang, D., Wilcock, G. K., Faragher, B., & Jamieson, G. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10149-5 · Cited by 669 · cited 1×
“Also, in support of the HSV1-APOE connection are the studies showing that APOE-e4 confers a strong risk of herpes labialis, a disorder of the peripheral nervous system known to be caused (usually) by HSV1 [3,38] and also the studies showing the greater potential for HSV1 damage in infected APOE-e4-transgenic mice comp…”
Self-citationHerpes simplex virus: receptors and ligands for cell entry
Spear, P. G. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00389.x · Cited by 581 · cited 1×
“The infectious cycle of HSV1 is a complex process, which begins with binding of the virus to heparan sulfate proteoglycan molecules on the cell surface. Subsequently the virus binds to more specific receptors which facilitate virus entry into the cell by fusion”
Preston, C. M. (1979) · Journal of Virology · doi:10.1128/jvi.29.1.275-284.1979 · Cited by 487 · cited 9×
“The presence of the ICP4 ts mutation in tsK/lacZ and in1374 was confirmed by comparison of titres at 32uC and 38.5uC.”
InfluentialSelf-citationHerpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques
Wozniak, M., Mee, A., & Itzhaki, R. (2009) · The Journal of Pathology · doi:10.1002/path.2449 · Cited by 464 · cited 4×
“Subsequently, the presence of HSV1 in the human brain was confirmed by several other groups (reviewed in [32]), using solution PCR.”
InfluentialSelf-citationEverett, R. D. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02270.x · Cited by 390 · cited 1×
“IE proteins include infected cell polypeptide (ICP) 0 and ICP4 which are transcriptional activators [18,19].”
Herpes simplex virus infection causes cellular β-amyloid accumulation and secretase upregulation
Wozniak, M. A., Itzhaki, R. F., Shipley, S. J., & Dobson, C. B. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.077 · Cited by 341
Self-citationJohnson, D. C., Frame, M. C., Ligas, M. W., Cross, A. M., & Stow, N. D. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1347-1354.1988 · Cited by 333 · cited 3×
“A viable HSV1 recombinant that specifies a truncated glycoprotein E (gE) (in1404), and fails to assemble a functional Fc receptor [24], did produce Ab and P-tau accumulation (Figure 1D and 2D), suggesting that the Ab and P-tau staining we observe is not an artefact due to the binding of the primary or secondary antibo…”
InfluentialLatent herpes simplex virus type 1 in normal and Alzheimer's disease brains
Jamieson, G. A., Maitland, N. J., Wilcock, G. K., Craske, J., & Itzhaki, R. F. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890330403 · Cited by 332 · cited 1×
“. Subsequent research demonstrated that the virus is present in the brain of most elderly subjects, including AD sufferers, and that it is present within the brain regions affected by AD”
Self-citationDeLuca, N. A., & Schaffer, P. A. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.8.1997 · Cited by 282
“Limbic Predilection in Alzheimer Dementia: Is Reactivated Herpesvirus Involved?”
Ball, M. J. (1982) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100044115 · Cited by 244 · cited 1×
“The first suggestion that HSV1 might have a role in AD was based on the observation that in HSE the brain regions damaged are the same ones as those that are affected in AD [1].”
Earnshaw, D. L., Bacon, T. H., Darlison, S. J., Edmonds, K., Perkins, R. M., & Vere Hodge, R. A. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2747 · Cited by 234 · cited 2×
“PCV, another guanine analogue, like ACV depends on the presence of the HSV1 TK, and its products block chain elongation of the viral DNA, but the two agents differ in their affinity for TK and the viral DNA polymerase: that of ACV is much greater for the TK, and that of PCV (as triphosphate) is much greater for the po…”
Wagstaff, A. J., & Bryson, H. M. (1994) · Drugs · doi:10.2165/00003495-199448020-00007 · Cited by 232
Ace, C. I., McKee, T. A., Ryan, J. M., Cameron, J. M., & Preston, C. M. (1989) · Journal of Virology · doi:10.1128/jvi.63.5.2260-2269.1989 · Cited by 231 · cited 1×
“The recombinant in1863 was produced by cotransfection of ScaI-cleaved pMJ101 with DNA of 1814R, anHSV1, strain 17, isolate that is analogous to WT virus [52], using the methods described above for the construction of tsK/lacZ.”
MethodSelf-citationPrevalence of Alzheimer plaques in AIDS
Esiri, M. M., Biddolph, S. C., & Morris, C. S. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.1.29 · Cited by 227
Alzheimer’s disease-specific tau phosphorylation is induced by herpes simplex virus type 1
Wozniak, M. A., Frost, A. L., & Itzhaki, R. F. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0963 · Cited by 216 · cited 1×
“Consistently, the enzymes involved in the generation of Ab and of (P-tau are increased in HSV1-infected cells [6,7,13].”
Self-citationCSF amyloid β42 and tau levels correlate with AIDS dementia complex
Brew, B. J., Pemberton, L., Blennow, K., Wallin, A., & Hagberg, L. (2005) · Neurology · doi:10.1212/01.wnl.0000183293.95787.b7 · Cited by 199
Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients
Wozniak, M. A., Shipley, S. J., Combrinck, M., Wilcock, G. K., & Itzhaki, R. F. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20271 · Cited by 177 · cited 1×
“and a totally different method, namely, detection of intrathecal antibodies in CSF from old people but not in CSF from infants”
Self-citationJamieson, G. A., Maitland, N. J., Wilcock, G. K., Yates, C. M., & Itzhaki, R. F. (1992) · The Journal of Pathology · doi:10.1002/path.1711670403 · Cited by 172 · cited 1×
“In contrast in the brain, it is usually absent in younger people: using solution PCR, we detected HSV1 DNA in many elderly brains but only in very few younger brains [30], and these results were substantiated by in situ PCR [14] and a totally different method, namely, detection of Figure 7.”
Self-citationThe virion transactivator of herpes simplex virus
O’Hare, P. (1993) · Seminars in Virology · doi:10.1006/smvy.1993.1010 · Cited by 154
HSV-1 promotes Ca2+-mediated APP phosphorylation and Aβ accumulation in rat cortical neurons
Piacentini, R., Civitelli, L., Ripoli, C., Marcocci, M. E., Chiara, G. D., Garaci, E., Azzena, G. B., Palamara, A. T., & Grassi, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.06.009 · Cited by 151 · cited 1×
“Two other groups have recently investigated HSV1-induced Aβ accumulation. Firstly, Piacentini et al.”
BackgroundDe Chiara, G., Marcocci, M. E., Civitelli, L., Argnani, R., Piacentini, R., Ripoli, C., Manservigi, R., Grassi, C., Garaci, E., & Palamara, A. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013989 · Cited by 150
Herpes Simplex Virus Type 1 in Alzheimer's Disease: The Enemy Within
Itzhaki, R. F., & Wozniak, M. A. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13405 · Cited by 143
Self-citationHerpesviruses in brains in Alzheimer's and Parkinson's diseases
Hemling, N., Röyttä, M., Rinne, J., Pöllänen, P., Broberg, E., Tapio, V., Vahlberg, T., & Hukkanen, V. (2003) · Annals of Neurology · doi:10.1002/ana.10662 · Cited by 142 · cited 1×
“However, two studies found HSV1 DNA only very rarely in human brains [33,34] and we have discussed the possible reasons for this [35,36].”
Santana, S., Recuero, M., Bullido, M. J., Valdivieso, F., & Aldudo, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.010 · Cited by 140
Zambrano, Á., Solis, L., Salvadores, N., Cortés, M., Lerchundi, R., & Otth, C. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14301 · Cited by 120 · cited 1×
“showed that in mouse primary neuronal cultures, 50 mM ACV prevented the neuronal death and neurite disruption induced by HSV1 [8].”
Acyclovir Levels in Serum and Cerebrospinal Fluid after Oral Administration of Valacyclovir
Lycke, J., Malmeström, C., & Ståhle, L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2438-2441.2003 · Cited by 111 · cited 1×
“However, this appears not be problematic since in people with normal blood-CSF barrier function, including those who have recovered from HSE, ACV (derived from VCV) has been shown to be present in CSF at the inhibitory level for HSV1 [47,48].”
The Receptor‐Binding Region of Human Apolipoprotein E Has Direct Anti‐Infective Activity
Dobson, C. B., Sales, S. D., Hoggard, P., Wozniak, M. A., & Crutcher, K. A. (2006) · The Journal of Infectious Diseases · doi:10.1086/499280 · Cited by 91 · cited 1×
“We used HSV1 strain SC16, which was prepared as previously described [49], and HSV1 strain 17.”
MethodSelf-citationJamieson, D. R. S., Robinson, L. H., Daksis, J. I., Nicholl, M. J., & Preston, C. M. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-6-1417 · Cited by 86 · cited 3×
“Insertion of the MIEP-lacZ cassette was achieved by co-transfection of ScaI-cleaved pMJ101 with tsK DNA, using methods described previously [51].”
MethodInfluentialSelf-citationHSV-1 in brain and risk of Alzheimer's disease
Beffert, U., Bertrand, P., Champagne, D. L., Gauthier, S. G., & Poirier, J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79057-7 · Cited by 83 · cited 1×
“In fact there is one study that showed consistent results [4] and a second that found a trend towards association [37].”
Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells
Lukiw, W. J., Cui, J. G., Yuan, L. Y., Bhattacharjee, P. S., Corkern, M., Clement, C., Kammerman, E. M., Ball, M. J., Zhao, Y., Sullivan, P. M., et al. (2010) · NeuroReport · doi:10.1097/wnr.0b013e32833da51a · Cited by 81 · cited 1×
“. Lukiw et al. investigated the effect of ACV on miRNA146a, an miRNA implicated as a negative regulator of the innate immune system in AD and several other diseases, and found that 30 µM ACV significantly countered the increase in level of the miRNA caused by HSV1”
BackgroundValacyclovir for Herpes Simplex Encephalitis
Pouplin, T., Pouplin, J. N., Van Toi, P., Lindegardh, N., Rogier van Doorn, H., Hien, T. T., Farrar, J., Török, M. E., & Chau, T. T. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01023-10 · Cited by 76 · cited 1×
“However, this appears not be problematic since in people with normal blood-CSF barrier function, including those who have recovered from HSE, ACV (derived from VCV) has been shown to be present in CSF at the inhibitory level for HSV1 [47,48].”
Alzheimer's disease, herpes virus in brain, apolipoprotein E4 and herpes labialis
Lin, W., Graham, J. B., MacGowan, S., Wilcock, G., & Itzhaki, R. F. (1998) · Alzheimers Reports · Cited by 74
Self-citationHIV Regulation of Amyloid Beta Production
Pulliam, L. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9151-9 · Cited by 64 · cited 1×
“A further argument against the role of HSV1 in AD is that Aβ and P-tau accumulation are not specific to HSV1. Indeed, other pathogens can produce AD-like changes – for example HIV causes Aβ and P-tau formation”
Activation of PKR Causes Amyloid ß-Peptide Accumulation via De-Repression of BACE1 Expression
ILL-Raga, G., Palomer, E., Wozniak, M. A., Ramos-Fernández, E., Bosch-Morató, M., Tajes, M., Guix, F. X., Galán, J. J., Clarimón, J., Antúnez, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021456 · Cited by 64
Self-citationThackray, A. M., & Field, H. J. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.2.291 · Cited by 64 · cited 1×
“On that basis, PCV might provide a better alternative as some studies suggest that it can reduce the frequency or extent of HSV1 reactivation [44-46].”
Godowski, P. J., & Knipe, D. M. (1985) · Journal of Virology · doi:10.1128/jvi.55.2.357-365.1985 · Cited by 62 · cited 1×
“Expression of gC is strictly dependent upon viral DNA synthesis [21].”
Antiviral agents in Alzheimer’s disease: hope for the future?
Wozniak, M. A., & Itzhaki, R. F. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610370069 · Cited by 59 · cited 3×
“immune response but presumably – as we have suggested [32] – over-produced eventually, with consequent harmful effects, then its elimination might well be counter-productive.”
Self-citationMcQuaid, S., Allen, I. V., McMahon, J., & Kirk, J. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb01168.x · Cited by 56 · cited 1×
“Indeed, other pathogens can produce AD-like changes – for example HIV causes Ab and P-tau formation [39–41], and measles virus causes neurofibrillary tangles formation [42], but currently only HSV1, unlike these other viruses, has been detected in normal or AD brains, and so is the only candidate agent.”
Koelle, D. M., Magaret, A., Warren, T., Schellenberg, G. D., & Wald, A. (2010) · Sexually Transmitted Infections · doi:10.1136/sti.2009.039735 · Cited by 51 · cited 1×
“Also, in support of the HSV1-APOE connection are the studies showing that APOE-e4 confers a strong risk of herpes labialis, a disorder of the peripheral nervous system known to be caused (usually) by HSV1 [3,38] and also the studies showing the greater potential for HSV1 damage in infected APOE-e4-transgenic mice comp…”
Lerchundi, R., Neira, R., Valdivia, S., Vio, K., Concha, M. I., Zambrano, A., & Otth, C. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101386 · Cited by 50
Preston, C. M., & Nicholl, M. J. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.525-535.2005 · Cited by 43 · cited 5×
“in1374 Mutations that inactivate VP16 transactivation function, ICP0 and ICP4, insertion of MIEP-lacZ at TK locus Enters cells but synthesizes IE proteins and b-gal in only a small subset of infected cells [22]”
InfluentialSelf-citationHerpes simplex virus and risk of Alzheimer's disease.
Itabashi, S., Arai, H., Matsui, T., Higuchi, S., & Sasaki, H. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62325-2 · Cited by 35
Lack of association between HSV-1 DNA in the brain, Alzheimer's disease and apolipoprotein E4
Marques, A. R., Straus, S. E., Fahle, G. A., Weir, S., Csako, G., & Fischer, S. H. (2001) · Journal of NeuroVirology · doi:10.1080/135502801300069773 · Cited by 32 · cited 1×
“However, two studies found HSV1 DNA only very rarely in human brains [33,34] and we have discussed the possible reasons for this [35,36].”
Herpes simplex virus type 1 and Alzheimer's disease
Itzhaki, R. F., Dobson, C. B., & Wozniak, M. A. (2004) · Annals of Neurology · doi:10.1002/ana.10852 · Cited by 26
Self-citationAssociation of HSV1 and apolipoprotein E-ϵ4 in Alzheimer's disease
Dobson, C. B. (2001) · Journal of NeuroVirology · doi:10.1080/135502801753248169 · Cited by 24
Cited by
Microbes and Alzheimer’s Disease
Itzhaki, R. F., Lathe, R., Balin, B. J., Ball, M. J., Bearer, E. L., Braak, H., Bullido, M. J., Carter, C., Clerici, M., Cosby, S. L., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160152 · Cited by 532
Self-citationSalminen, A., Kaarniranta, K., Kauppinen, A., Ojala, J., Haapasalo, A., Soininen, H., & Hiltunen, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.002 · Cited by 364
Harris, S. A., & Harris, E. A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142853 · Cited by 279
“Acyclovir decreased A by reducing cellular viral spreading and decreased tau phosphorylation by interfering with viral replication [166].”
BackgroundInfluentialCorroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer’s Disease
Itzhaki, R. F. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00324 · Cited by 256
Self-citationA 3D human brain–like tissue model of herpes-induced Alzheimer’s disease
Cairns, D. M., Rouleau, N., Parker, R. N., Walsh, K. G., Gehrke, L., & Kaplan, D. L. (2020) · Science Advances · doi:10.1126/sciadv.aay8828 · Cited by 247
“While previous reports have suggested a potential link between HSV-1 and up-regulation of certain AD mediators (31), to date, no direct causality of AD by herpes virus in a 3D human brain model has been demonstrated.”
Background
Metadata
- Authors
- Wozniak, M. A., Frost, A. L., Preston, C. M., & Itzhaki, R. F.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-07
- Volume
- 6
- Issue
- 10
- Pages
- e25152
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2092871280
- Cited by
- 172
- References
- 46
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.